Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Frydrychowicz, , Andrzej,
DOB: 12-APR-1974 (Age: 51)
Gender: male
Address:
aleja Tulipanowa 94
21-040 Świdnik (Poland)
ID: 7036-931598-4 (ECI)
Report
Date: 16-MAR-2019
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Lubelskie Centrum Diagnostyczne
Aleja Lotników Polskich 82
21-040 Świdnik (Poland)
Specimen
Collected: 16-MAR-2019

Chemistry

Test 16-MAR-2019 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 4.3 - 6.4 %
Glucose [Mass/volume] in Blood 79.6 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.4 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.1 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 107.6 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 26.1 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All results are within normal limits except for a mildly elevated creatinine, which may indicate reduced kidney function. Glucose and HbA1c are at the upper end of normal, suggesting good glycemic control but continued monitoring is advised. No acute abnormalities detected; recommend follow-up of renal function.